IBTK and cancer: Many risk factors are known to influence infection severity in cancer patients, including delayed admission, low sensitivity, or wrong interpretation of the SARS‐CoV‐2 RT‐PCR tests, cancer treatment (including chemotherapy, targeted therapy, radiotherapy, immunotherapy, and treatment regimens containing JAKi or BTKi, as well as treatment with high‐dose corticosteroids and ICIs).